This information is intended for patients prescribed apixaban in the UK only.

To access information on your condition and treatment with apixaban, please enter the last six digits of the barcode printed on your apixaban box.

Last six digits of barcode:

Please enter 6 digit code

Invalid code - please try again

Report Side Effects

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. Side effects for this medicine should also be reported to Bristol Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com.

ADVERSE EVENTS

Adverse events should be reported. Reporting forms and information can be found via: United Kingdom – The yellow card scheme at http://www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via 0800 731 1736 or medical.information@bms.com.

Eliquis
BMS pfizer
BMS pfizer

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.

© 2021 Bristol-Myers Squibb Pharmaceuticals Limited

All corporate names and logos of BMS and / or its products are trademarks of Bristol-Myers Squibb Company and are protected by national and international intellectual and industrial property laws. All rights reserved over the content of this website.

Your use of this website is subject to the Legal Notice, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations.

432-GB-2100425 | Date of preparation: September 2021

  • Home
  • Site map
  • Privacy Policy
  • Legal Notice
  • Pharmacovigilance Notice
  • Contact
  • Home
  • Site map
  • Privacy Policy
  • Legal Notice
  • Pharmacovigilance Notice
  • Contact